Newron Pharmaceuticals SpA - Company Profile
Powered by 
All the sales intelligence you need on Newron Pharmaceuticals SpA in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Newron Pharmaceuticals SpA fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Newron Pharmaceuticals SpA.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Newron Pharmaceuticals SpA patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| US20220185766A1 | Application | PROCESS FOR THE PRODUCTION OF SUBSTITUTED 2-[2-(PHENYL)ETHYLAMINO]ALKANEAMIDE DERIVATIVES | C07B2200/05; C07B59/001; C07C231/12; C07C231/14; C07C41/14; C07C45/64 | June 16, 2022 |
| US20220177417A1 | Application | PROCESS FOR THE PRODUCTION OF SUBSTITUTED 2-[2-(PHENYL) ETHYLAMINO]ALKANEAMIDE DERIVATIVES | C07C231/12 | June 09, 2022 |
| MA55714A | Application | PROCÉDÉ DE PRODUCTION DE DÉRIVÉS DE 2-[2-(PHÉNYL) ÉTHYLAMINO]ALCANEAMIDE SUBSTITUÉS | A61K31/16; C07B2200/05; C07B59/001; C07C231/12; C07C231/14; C07C237/06; C07C41/14; C07C41/30; C07C43/215; C07C45/513; C07C45/64; C07C47/277 | February 23, 2022 |
| EP3956295A1 | Application | VERFAHREN ZUR HERSTELLUNG VON SUBSTITUIERTEN 2-[2-(PHENYL)ETHYLAMINO]ALKANAMID-DERIVATEN | A61K31/16; C07C213/00; C07C217/60; C07C231/12; C07C237/06; C07C253/08; C07C255/36 | February 23, 2022 |
| MA55710A | Application | PROCÉDÉ DE PRODUCTION DE DÉRIVÉS DE 2-[2-(PHÉNYL)ÉTHYLAMINO]ALCANEAMIDE SUBSTITUÉS | A61K31/16; C07C213/00; C07C217/60; C07C231/12; C07C237/06; C07C253/08; C07C255/36 | February 23, 2022 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer